About Improve Medical Instruments Company

The company was founded in 1996. It is a high-tech enterprise that has been engaged in mutation control research for 27 years before specimen analysis. It has been deeply involved in becoming a leader in the domestic venous specimen collection field and is at the top of the global industry rankings. In 2009, Yangpu Medical entered the Shenzhen Stock Exchange GEM. The company's main business is testing services, smart medical care, precision medicine, etc. The company's main products include: vacuum blood collection systems, liquid biopsy tubes, fully automatic blood collection and capping machines, intelligent blood collection and sorting systems, customized software systems, thromboelastography instruments and reagents, rare cell sorters (AF-RCFS series) and reagents, rare cell sorting chips & filters (rare cell capture microfluidic control chips), rare cell isolation and multi-dimensional detection platforms, tumor testing, pathogen detection, genetic disease testing, drug sensitivity testing, etc. Company honors: Guangdong High-tech Enterprise, National Intellectual Property Advantage Enterprise, Guangdong Import and Export Famous Brand Enterprise, etc.